Literature DB >> 33753839

Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders.

Yusuke Kashiwagi1, Tomohisa Nagoshi2, Yasunori Inoue2, Yoshiro Tanaka2, Hirotake Takahashi2, Yuhei Oi2, Haruka Kimura2, Kousuke Minai2, Michihiro Yoshimura2.   

Abstract

In patients with cardiovascular disorders, blood total ketone body (TKB) levels increase with worsening heart failure and are consumed as an alternative fuel to fatty acid and glucose. We investigated factors contributing to the increase in the blood TKB levels in patients with cardiovascular disorders. The study population consisted of 1030 consecutive patients who underwent cardiac catheterization. Covariance structure analyses were performed to clarify the direct contribution of hemodynamic parameters, including the left ventricular end-diastolic pressure (LVEDP), left ventricular end-systolic volume index (LVESVI), left ventricular end-diastolic volume index (LVEDVI), and B-type natriuretic peptide (BNP) levels, to TKB by excluding other confounding factors. These analyses showed that the TKB levels were significantly associated with the BNP level (P = 0.003) but not the LVEDP, LVESVI, or LVEDVI levels. This was clearly demonstrated on a two-dimensional contour line by Bayesian structure equation modeling. The TKB level was positively correlated with the BNP level, but not LVEDP, LVESVI or LVEDVI. These findings suggested that elevated blood TKB levels were more strongly stimulated by the increase in BNP than by hemodynamic deterioration. BNP might induce the elevation of TKB levels for use as an important alternative fuel in the failing heart.

Entities:  

Year:  2021        PMID: 33753839      PMCID: PMC7985483          DOI: 10.1038/s41598-021-86126-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

2.  Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.

Authors:  H P Brunner-La Rocca; D M Kaye; R L Woods; J Hastings; M D Esler
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

3.  Increase in oxidized low-density lipoprotein level according to hyperglycemia in patients with cardiovascular disease: A study by structure equation modeling.

Authors:  Takayuki Yamada; Kazuo Ogawa; Toshikazu D Tanaka; Tomohisa Nagoshi; Kosuke Minai; Takayuki Ogawa; Makoto Kawai; Michihiro Yoshimura
Journal:  Diabetes Res Clin Pract       Date:  2020-01-29       Impact factor: 5.602

Review 4.  Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure.

Authors:  M Yoshimura; H Yasue; H Ogawa
Journal:  Can J Physiol Pharmacol       Date:  2001-08       Impact factor: 2.273

Review 5.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

Review 6.  Control of lipolysis by natriuretic peptides and cyclic GMP.

Authors:  Max Lafontan; Cédric Moro; Michel Berlan; François Crampes; Coralie Sengenes; Jean Galitzky
Journal:  Trends Endocrinol Metab       Date:  2008-03-11       Impact factor: 12.015

7.  Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis.

Authors:  Sunder Mudaliar; Sindura Alloju; Robert R Henry
Journal:  Diabetes Care       Date:  2016-07       Impact factor: 19.112

8.  Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.

Authors:  Kenneth C Bedi; Nathaniel W Snyder; Jeffrey Brandimarto; Moez Aziz; Clementina Mesaros; Andrew J Worth; Linda L Wang; Ali Javaheri; Ian A Blair; Kenneth B Margulies; J Eduardo Rame
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

9.  The Failing Heart Relies on Ketone Bodies as a Fuel.

Authors:  Gregory Aubert; Ola J Martin; Julie L Horton; Ling Lai; Rick B Vega; Teresa C Leone; Timothy Koves; Stephen J Gardell; Marcus Krüger; Charles L Hoppel; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Daniel P Kelly
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

10.  Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study.

Authors:  Mitsutoshi Tominaga; Makoto Kawai; Kosuke Minai; Kazuo Ogawa; Yasunori Inoue; Satoshi Morimoto; Toshikazu Tanaka; Tomohisa Nagoshi; Takayuki Ogawa; Michihiro Yoshimura
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

View more
  2 in total

1.  Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure.

Authors:  Hirotake Takahashi; Yusuke Kashiwagi; Tomohisa Nagoshi; Yoshiro Tanaka; Yuhei Oi; Haruka Kimura; Kousuke Minai; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

2.  SGLT2 Inhibitors and Ketone Metabolism in Heart Failure.

Authors:  Huitzilihuitl Saucedo-Orozco; Suzanne N Voorrips; Salva R Yurista; Rudolf A de Boer; B Daan Westenbrink
Journal:  J Lipid Atheroscler       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.